COMPANY PROFILE

BioCircuit Technologies

Explore full profile

Develops non-invasive electrophysiology devices which monitor, control, and repair peripheral nerves

Atlanta, United StatesFounded 2016Biotech & Life Sciences

Valuation $100–250M Last recorded · 2026

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About BioCircuit Technologies

BioCircuit Technologies specializes in advanced nerve repair solutions, primarily through its flagship product, Nerve Tape. This innovative medical device is designed to repair peripheral nerve discontinuities more effectively than traditional microsutures. Nerve Tape is 2.6 times stronger and 4.8 times faster than conventional microsuture repairs, significantly reducing surgery time and improving patient outcomes. The company serves healthcare providers, particularly in the fields of neurosurgery and orthopedics, operating within the medical device market. BioCircuit Technologies generates revenue through the sale of Nerve Tape to hospitals, clinics, and surgical centers. The business model focuses on providing a superior alternative to existing nerve repair methods, thereby enhancing the efficiency and success rates of nerve surgeries.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2016
Headquarters: Atlanta, United States
Employees: 46
Open positions: 1
Dealroom signal: 86.8/100
Industry: Health
Sub-industry: BioTechnology, Medical Devices
Sector: Biotech & Life Sciences, Biotechnology, Core AI, Hard Tech, AI Applications, DT and LS, science-based
Technology: Artificial Intelligence, Deep Tech, Machine Learning
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
GRANTOther financing	Oct 2023	$2.4M	—	National Institutes of Health	↗
SEED✓Equity / VC	Sep 2022	$9M	$36M	GRA Venture Fund · Alsora Capital · Michael Masters	↗

Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

BioCircuit Technologies website traffic

Latest recorded traffic for BioCircuit Technologies is 1.9K monthly website visits, up 5.6% over the last three months. BioCircuit Technologies's team grew 4.5% over the past year.

Latest monthly visits1.9K 3-month web change+5.6% 1-year team growth+4.5%

Monthly website visitsOct 2022–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Medical Affairs Manager | Medical DeviceAtlanta, GA · Other · Feb 24, 2026

1 distinct opening shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
PIPicturaBioBuilding instant pathogen tests using super-resolution microscopy and machine learning	Oxford, United Kingdom	Operational	16	$3.8M	$14M
DIDecorte Future IndustriesDevelops adaptive intelligent clothing with AI powered controls	Milton, United Kingdom	Operational
R(Research Grid (R.grid)AI-powered automation engine for admin-free clinical trials	Norwich, United Kingdom	Operational
OIOiviPreventing blindness among diabetes patients by deploying an AI-camera for automated diagnosis of retinal diseases	Oslo, Norway	Operational
THTHERAPANACEADevotion to Innovation, Compassion for Patients, Artificial Intelligence for Cancer Care	Paris, France	Operational
GLGlowDxA start-up company that aims to deliver diagnostic accessibility through bio-molecular innovation	Kilkenny, Ireland	Operational
KEKeen EyeAnalyzes and reviews slide images	Paris, France	Closed
MIMindMazeDigital neuro-therapeutics for brain health and recovery	Lausanne, Switzerland	Acquired